Swiss cannabis operator with EU-GMP compliant facility seeks strategic partner to become a dominant force in the EU
A Swiss cannabis cultivator and processor, supplying premium cannabis flowers and extracts to the pharmaceutical market, is seeking a strategic equity partner to fuel its continued growth. Positioned to become a leading player in the European cannabis industry, the company is primed for rapid expansion.
Listing ID:
16830162284
Licence(s) Held:
GACP, SwissMedic - medical cannabis license for cultivation and distribution and pending EU-GMP certification
Seeking equity partner to invest CHF 6 million in exchange for a 20% stake in the company to support ongoing expansion and growth. Open to bridge loan finance or other M&A options.
Listing Details:
A Swiss pharma-centric medical cannabis company specializing in indoor production and distribution of premium, high-quality, medical cannabis flowers
The company operates in a purpose built, 10,000 m² leased facility, featuring 25 grow rooms, state-of-the-art chemistry and biology labs, and a GMP-certified cleanroom for microbiological testing of finished products.
The company is currently operating the initial production phase and is generating revenue with secured contracts totaling CHF 7 million
Full production commences in Q1 2025, with expected sales ramping up to CHF 40 million and a target of CHF 70 million by 2026 through the addition of cannabis extraction and branded product launches
Has invested between 60 and 70 million CHF to build out the entire site
Company is waiting to obtain EU-GMP certification, which is expected imminently
Experienced, industry-leading international team with deep expertise navigating global medical cannabis markets
Company aims to secure a leading position in the DACH region (Germany, Austria and Switzerland) and globally, emphasizing R&D and sustainability to establish a strong position in the medical cannabis market and build consumer trust through the promotion of cannabis-based health benefits
Company has secured several initial offtake agreements, ensuring timely, efficient and continuous production and distribution of medical cannabis
Investing in the company will facilitate the development of a full-scale production process and secure additional offtake agreements to fully utilize the annual capacity of 18 tons
Seeking an equity partner to invest up to 6 million CHF in exchange for a stake in the company, with funds allocated to launch GMP-certified indoor cannabis production facility. Open for bridge loan or full divestiture opportunities.
16830162284
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
18925796406
Established Alberta cannabis brand with 18 AGLC-Approved SKUs & 6,000 Sq. Ft. cultivation and processing facility – $350K Asset Sale
An operating cannabis brand in Northern Alberta — 40 minutes from the AGLC warehouse — with 18 AGLC-approved SKUs, and a 6,000 sq ft licensed facility, available as a $350,000 asset sale of brand, inventory, and lease.
6891632282
Turnkey, EU GMP & GACP-Certified Canadian Medical Cannabis Producer & International Export Hub for Sale
Rare opportunity to acquire a profitable, fully licensed, EU-GMP certified Canadian medical cannabis producer with international export access. One of fewer than 12 EU-GMP certifications among 800+ Canadian LPs.
3433737347
Turnkey, GACP & CUMCS-Certified 54,000 sq. ft. Cannabis Infrastructure & International Export Hub in Montreal, QC for Sale!
A rare opportunity to acquire a fully licensed, debt-free cannabis enterprise in QC with $11.5M in 2025 revenue, dual international export certifications, and turnkey access to the Quebec market. The sale includes all Health Canada licences, brand IP, equipment, and leasehold operational infrastructure.